Vietnam Pharmaceuticals Market is Expected to be Dominated by Generic Drugs through 2028
During
the forecast period, an increasing prevalence of chronic diseases is
anticipated to fuel market expansion in the Vietnam pharmaceuticals market.
According to TechSci Research report, “Vietnam Pharmaceuticals Market - By
Region, Competition, Forecast and Opportunities, 2028”, the pharmaceuticals
market in Vietnam is growing rapidly with a CAGR 8.19%. Vietnam is one of
Southeast Asia’s fastest growing economies, making it an ideal market for
pharmaceutical companies to expand their business.
Vietnam’s pharmaceuticals market is growing due to several factors. The
country’s population is increasing, with over 97 million people living in the
country. This is increasing the demand for health care services and medicinal
products. Vietnam’s middle class is growing, making healthcare products more
affordable and accessible.
In addition, government initiatives, such as improving healthcare
infrastructure and increasing health insurance coverage have also contributed
to the rise in pharmaceutical consumption. As more and more people access
healthcare, the need for pharmaceuticals has increased.
One of the key challenges is a lack of domestic manufacturing capability for
complex and valuable drugs. Vietnam imports most of its pharmaceutical
products, which makes it prone to supply chain issues and international market
price volatility.
In addition, counterfeit drugs are a common issue in Vietnam. Not only does
this put patients’ health at risk, but it also weakens consumer confidence in
pharmaceutical products, which could lead to a decrease in demand.
Vietnam pharmaceuticals market is expected to grow in the coming years due to
the growing emphasis on R&D activities. As the government aims to encourage
domestic drug production and decrease dependence on imports, R&D
investments have increased. This could lead to more innovation in the market.
In addition, there is an increasing interest in traditional medicine and
natural remedies in Vietnam. Due to the country’s rich herbal heritage,
traditional medicine is popular in Vietnam. This has caused the demand for
herbal pharmaceuticals and herbal supplements to increase in the area.
COVID-19 has had a major impact on the global pharmaceutical industry, and
Vietnam has been no exception. While supply chains have been disrupted and
logistics have been a challenge, the pandemic has also given local
pharmaceutical companies the opportunity to demonstrate their ability to
produce critical medical supplies.
In addition, the COVID-19 pandemic has hastened the development of digital
health and telehealth in Vietnam. Due to restrictions on movement and contact,
virtual healthcare consultation and e-pharmacies gained momentum, changing the
way healthcare is provided.
Browse over 20 market data Figures spread through 105 Pages and an
in-depth TOC on "Vietnam Pharmaceuticals Market.”
The Vietnam pharmaceuticals market can be segmented by drug type, product type,
application, distribution channel, and region.
Based on drug type, the market can be segmented into generic drugs and branded
drugs. Generic drugs have acquired the highest share of 61.73% in 2022 due to
several key factors that make them a preferred choice among both consumers and
healthcare providers. Generic drugs are medications that are equivalent to
brand-name drugs in terms of active ingredients, dosage, safety, efficacy, and
intended use. They are typically produced after the patent of the original
brand-name drug expires, allowing other pharmaceutical companies to manufacture
and sell them at lower prices.
In terms of product type, the market can be divided into prescription drugs and
over-the-counter drugs. In 2022, prescription drugs have acquired the highest
share of 69.73% in the Vietnam pharmaceutical market due to several reasons
that make them essential for healthcare providers and patients alike.
Prescription drugs, also known as prescription medications, are medications
that require a written or electronic order from a licensed healthcare
professional, such as a doctor or a nurse practitioner.
Major companies operating in Vietnam pharmaceuticals market include:
Bayer
Vietnam Ltd.
DHG
Pharmaceutical Joint Stock Company
Traphaco
Joint Stock Company
Ha
Tay Pharmaceutical Joint Stock Company
Domesco
Medical Import Export Joint Stock Corporation (DOMESCO)
OPC
Pharmaceutical Joint Stock Company
Sanofi
SA
Mekophar
Chemical and Pharmaceutical JSC
Imexpharm
Corporation
PYMEPHARCO
Joint Stock Company (STADA Arzneimittel AG)
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“Vietnam’s pharmaceutical market is growing rapidly due to several factors. A
growing middle class with higher disposable income has increased their
healthcare spending, leading to an increase in pharmaceutical demand. Also, a
rapidly ageing population has increased the market for drugs that address age
related health conditions. Manufacturing processes and research capacities have
improved, allowing local pharma companies to improve their product range and
quality, increasing competition and innovation within the sector. However, the
coronavirus pandemic presented challenges and opportunities to the market.
Demand for some medications and vaccines increased, but supply chain disruptions
and logistical issues posed challenges. Pharmaceutical companies that showed
resilience and flexibility thrived during the pandemic.” said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based global management
consulting firm.
“Vietnam Pharmaceuticals Market, By Drug Type (Generic Drugs, Branded Drugs),
By Product Type (Prescription Drugs, Over-The-Counter Drugs), By Application
(Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder,
Others), By
Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By
Region, Competition, Forecast and Opportunities, 2028”, has evaluated the
future growth potential of Vietnam pharmaceuticals market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers, challenges,
and opportunities in Vietnam pharmaceuticals market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com